임상시험

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

NCT: NCT04796350 · RECRUITING

NCT IDNCT04796350

상태RECRUITING

시작일2021-04-24

완료2029-04-01

SponsorAgNovos Healthcare, LLC (INDUSTRY)

First posted2021-03-12

Last updated2026-05-13

간략 요약

A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 years after undergoing hip fracture repair surgery.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.